Drawing for CLINPASS

USPTO serial 78301432

CLINPASS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
MARTIN, EUGENIA K
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CLINPASS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009computer software, namely, statistical software for data processing, statistical analysis, creating tables, listing reports and graphing of new drug submission data for use in the drug approval process in FDA or NDA, and for use in clinical trials in the pharmaceutical, medical device, biopharmaceutical and biotechnology fieldsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 17, 2006UNDCUNDELIVERABLE MAIL - COURTESY COPY MAILED
Mar 13, 2006MAILPAPER RECEIVED
Mar 7, 2006MAB6ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Mar 7, 2006ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 6, 2005EX1GSOU EXTENSION 1 GRANTED
May 6, 2005EXT1SOU EXTENSION 1 FILED
May 6, 2005EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 4, 2005NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 12, 2004PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 22, 2004NPUBNOTICE OF PUBLICATION
Aug 13, 2004PREVLAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 9, 2004ALIEASSIGNED TO LIE
Jul 30, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jul 29, 2004GNEAEXAMINERS AMENDMENT E-MAILED
Jul 19, 2004EMRVEMAIL RECEIVED
May 13, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
May 13, 2004TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 13, 2004TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
May 13, 2004TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 19, 2004GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 13, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 8, 2004DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance